Annual Cash & Cash Equivalents
$23.55 M
-$19.59 M-45.42%
December 31, 2023
Summary
- As of February 7, 2025, MBRX annual cash & cash equivalents is $23.55 million, with the most recent change of -$19.59 million (-45.42%) on December 31, 2023.
- During the last 3 years, MBRX annual cash & cash equivalents has risen by +$8.38 million (+55.21%).
- MBRX annual cash & cash equivalents is now -66.79% below its all-time high of $70.90 million, reached on December 31, 2021.
Performance
MBRX Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$9.40 M
-$1.44 M-13.28%
September 30, 2024
Summary
- As of February 7, 2025, MBRX quarterly cash and cash equivalents is $9.40 million, with the most recent change of -$1.44 million (-13.28%) on September 30, 2024.
- Over the past year, MBRX quarterly cash and cash equivalents has dropped by -$7.42 million (-44.10%).
- MBRX quarterly cash and cash equivalents is now -89.10% below its all-time high of $86.29 million, reached on March 31, 2021.
Performance
MBRX Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
MBRX Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -45.4% | -44.1% |
| 3 y3 years | +55.2% | -70.8% |
| 5 y5 years | +230.1% | -70.8% |
MBRX Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -66.8% | at low | -86.7% | at low |
| 5 y | 5-year | -66.8% | +119.4% | -89.1% | at low |
| alltime | all time | -66.8% | >+9999.0% | -89.1% | +3521.5% |
Moleculin Biotech Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $9.40 M(-13.3%) |
| Jun 2024 | - | $10.85 M(-35.5%) |
| Mar 2024 | - | $16.82 M(-28.6%) |
| Dec 2023 | $23.55 M(-45.4%) | $23.55 M(-4.2%) |
| Sep 2023 | - | $24.58 M(-23.6%) |
| Jun 2023 | - | $32.17 M(-13.7%) |
| Mar 2023 | - | $37.27 M(-13.6%) |
| Dec 2022 | $43.15 M(-39.1%) | $43.15 M(-14.4%) |
| Sep 2022 | - | $50.39 M(-13.1%) |
| Jun 2022 | - | $58.00 M(-12.3%) |
| Mar 2022 | - | $66.10 M(-6.8%) |
| Dec 2021 | $70.90 M(+367.3%) | $70.90 M(-5.7%) |
| Sep 2021 | - | $75.18 M(-5.4%) |
| Jun 2021 | - | $79.51 M(-7.9%) |
| Mar 2021 | - | $86.29 M(+468.7%) |
| Dec 2020 | $15.17 M | $15.17 M(+18.6%) |
| Sep 2020 | - | $12.79 M(-23.5%) |
| Jun 2020 | - | $16.73 M(+43.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | $11.65 M(+8.5%) |
| Dec 2019 | $10.73 M(+50.5%) | $10.73 M(-30.3%) |
| Sep 2019 | - | $15.41 M(-17.6%) |
| Jun 2019 | - | $18.70 M(+112.9%) |
| Mar 2019 | - | $8.78 M(+23.1%) |
| Dec 2018 | $7.13 M(-7.5%) | $7.13 M(-17.0%) |
| Sep 2018 | - | $8.60 M(-26.6%) |
| Jun 2018 | - | $11.72 M(-10.6%) |
| Mar 2018 | - | $13.11 M(+70.0%) |
| Dec 2017 | $7.71 M(+54.1%) | $7.71 M(-11.7%) |
| Sep 2017 | - | $8.74 M(-5.8%) |
| Jun 2017 | - | $9.27 M(+4.4%) |
| Mar 2017 | - | $8.88 M(+77.4%) |
| Dec 2016 | $5.01 M(>+9900.0%) | $5.01 M(-19.0%) |
| Sep 2016 | - | $6.18 M(-14.6%) |
| Jun 2016 | - | $7.24 M(+2689.6%) |
| Mar 2016 | - | $259.70 K |
| Dec 2015 | $28.10 K | - |
FAQ
- What is Moleculin Biotech annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Moleculin Biotech?
- What is Moleculin Biotech annual cash & cash equivalents year-on-year change?
- What is Moleculin Biotech quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Moleculin Biotech?
- What is Moleculin Biotech quarterly cash and cash equivalents year-on-year change?
What is Moleculin Biotech annual cash & cash equivalents?
The current annual cash & cash equivalents of MBRX is $23.55 M
What is the all time high annual cash & cash equivalents for Moleculin Biotech?
Moleculin Biotech all-time high annual cash & cash equivalents is $70.90 M
What is Moleculin Biotech annual cash & cash equivalents year-on-year change?
Over the past year, MBRX annual cash & cash equivalents has changed by -$19.59 M (-45.42%)
What is Moleculin Biotech quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of MBRX is $9.40 M
What is the all time high quarterly cash and cash equivalents for Moleculin Biotech?
Moleculin Biotech all-time high quarterly cash and cash equivalents is $86.29 M
What is Moleculin Biotech quarterly cash and cash equivalents year-on-year change?
Over the past year, MBRX quarterly cash and cash equivalents has changed by -$7.42 M (-44.10%)